125 related articles for article (PubMed ID: 35147671)
1. Predictive factors and prognosis of microscopic residual disease in non-small-cell lung cancer surgery.
Rabinel P; Vergé R; Cazaux M; Mazzoni L; Renaud C; Rouch A; Brouchet L
Eur J Cardiothorac Surg; 2022 Sep; 62(4):. PubMed ID: 35147671
[TBL] [Abstract][Full Text] [Related]
2. Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancer.
Hofmann HS; Taege C; Lautenschläger C; Neef H; Silber RE
Eur J Cardiothorac Surg; 2002 Apr; 21(4):606-10. PubMed ID: 11932154
[TBL] [Abstract][Full Text] [Related]
3. The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non-Small Cell Lung Cancer.
Edwards JG; Chansky K; Van Schil P; Nicholson AG; Boubia S; Brambilla E; Donington J; Galateau-Sallé F; Hoffmann H; Infante M; Marino M; Marom EM; Nakajima J; Ostrowski M; Travis WD; Tsao MS; Yatabe Y; Giroux DJ; Shemanski L; Crowley J; Krasnik M; Asamura H; Rami-Porta R;
J Thorac Oncol; 2020 Mar; 15(3):344-359. PubMed ID: 31731014
[TBL] [Abstract][Full Text] [Related]
4. Significance of lymphangiosis carcinomatosa at the bronchial resection margin in patients with non-small cell lung cancer.
Passlick B; Sitar I; Sienel W; Thetter O; Morresi-Hauf A
Ann Thorac Surg; 2001 Oct; 72(4):1160-4. PubMed ID: 11603430
[TBL] [Abstract][Full Text] [Related]
5. Treatment and survival after lung resection for non-small cell lung cancer in patients with microscopic residual disease at the bronchial stump.
Ghiribelli C; Voltolini L; Paladini P; Luzzi L; Di Bisceglie M; Gotti G
Eur J Cardiothorac Surg; 1999 Nov; 16(5):555-9. PubMed ID: 10609907
[TBL] [Abstract][Full Text] [Related]
6. Validation of the IASLC Residual Tumor Classification in Patients With Stage III-N2 Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiotherapy Followed By Surgery.
Lee J; Lee J; Hong YS; Lee G; Kang D; Yun J; Jeon YJ; Shin S; Cho JH; Choi YS; Kim J; Zo JI; Shim YM; Guallar E; Cho J; Kim HK
Ann Surg; 2023 Jun; 277(6):e1355-e1363. PubMed ID: 35166266
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.
Osarogiagbon RU; Lin CC; Smeltzer MP; Jemal A
J Thorac Oncol; 2016 Jan; 11(1):e5-16. PubMed ID: 26762752
[TBL] [Abstract][Full Text] [Related]
8. Microscopic residual disease after resection for lung cancer: a multifaceted but poor factor of prognosis.
Riquet M; Achour K; Foucault C; Le Pimpec Barthes F; Dujon A; Cazes A
Ann Thorac Surg; 2010 Mar; 89(3):870-5. PubMed ID: 20172145
[TBL] [Abstract][Full Text] [Related]
9. Residual disease at the bronchial stump after curative resection for lung cancer.
Wind J; Smit EJ; Senan S; Eerenberg JP
Eur J Cardiothorac Surg; 2007 Jul; 32(1):29-34. PubMed ID: 17466532
[TBL] [Abstract][Full Text] [Related]
10. Surgery for young patients with lung cancer.
Tian DL; Liu HX; Zhang L; Yin HN; Hu YX; Zhao HR; Chen DY; Han LB; Li Y; Li HW
Lung Cancer; 2003 Nov; 42(2):215-20. PubMed ID: 14568689
[TBL] [Abstract][Full Text] [Related]
11. [Incomplete resections in bronchial carcinoma: morbidity and prognosis].
Dienemann H; Trainer C; Hoffmann H; Bülzebruck H; Muley T; Kayser K; Vogt-Moykopf I
Chirurg; 1997 Oct; 68(10):1014-9. PubMed ID: 9453893
[TBL] [Abstract][Full Text] [Related]
12. The present status of surgery for lung cancer.
Lacquet LK
Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
[TBL] [Abstract][Full Text] [Related]
13. Significance of R1-resection at the bronchial margin after surgery for non-small-cell lung cancer.
Lee GD; Kim DK; Jang SJ; Choi SH; Kim HR; Kim YH; Park SI
Eur J Cardiothorac Surg; 2017 Jan; 51(1):176-181. PubMed ID: 27401705
[TBL] [Abstract][Full Text] [Related]
14. The prognostic factors of resected non-small cell lung cancer with chest wall invasion.
Lee CY; Byun CS; Lee JG; Kim DJ; Cho BC; Chung KY; Park IK
World J Surg Oncol; 2012 Jan; 10():9. PubMed ID: 22236955
[TBL] [Abstract][Full Text] [Related]
15. [Prognosis of non-small cell lung cancer patients with microscopic residual disease at bronchial stump after lung resection].
Dai W; Yu C; Sun Y
Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(15):1022-4. PubMed ID: 12194790
[TBL] [Abstract][Full Text] [Related]
16. Unsuspected residual disease at the resection margin after surgery for lung cancer: fate of patients after long-term follow-up.
Lequaglie C; Conti B; Brega Massone PP; Giudice G
Eur J Cardiothorac Surg; 2003 Feb; 23(2):229-32. PubMed ID: 12559347
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of prognostic factors and efficacy of surgical treatment for non-small cell lung cancer: department of surgery NTLDRI (1998-1999)].
Chabowski M; Orłowski TM; Rabczenko D
Pneumonol Alergol Pol; 2008; 76(1):1-10. PubMed ID: 18283649
[TBL] [Abstract][Full Text] [Related]
18. The progression of non-small cell lung cancer from diagnosis to surgery.
McPherson I; Bradley NA; Govindraj R; Kennedy ED; Kirk AJB; Asif M
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1882-1887. PubMed ID: 32847696
[TBL] [Abstract][Full Text] [Related]
19. Bronchial resection margin length and clinical outcome in non-small cell lung cancer.
Tomaszek SC; Kim Y; Cassivi SD; Jensen MR; Shen KH; Nichols FC; Deschamps C; Wigle DA
Eur J Cardiothorac Surg; 2011 Nov; 40(5):1151-6. PubMed ID: 21450488
[TBL] [Abstract][Full Text] [Related]
20. Assessing the prognostic impact of the International Association for the Study of Lung Cancer proposed definitions of complete, uncertain, and incomplete resection in non-small cell lung cancer surgery.
Gagliasso M; Migliaretti G; Ardissone F
Lung Cancer; 2017 Sep; 111():124-130. PubMed ID: 28838382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
